<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infection due to coagulase-negative staphylococci: Clinical manifestations</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infection due to coagulase-negative staphylococci: Clinical manifestations</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infection due to coagulase-negative staphylococci: Clinical manifestations</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">JoAnn M Tufariello, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Franklin D Lowy, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Coagulase-negative staphylococci (CoNS) are a major constituent of human skin and mucosal commensal flora [<a href="#rid1">1,2</a>]. Once considered relatively avirulent and a likely contaminant when isolated from a clinical specimen, these organisms have increasingly been recognized as a cause of clinically significant nosocomial bloodstream infections. Patients at particular risk include those with prosthetic valves, pacemakers, defibrillators, ventricular assist devices, intravascular catheters, or other foreign bodies as well as neonates and immunocompromised hosts. These infections are inherently difficult to treat given the propensity of these organisms to colonize foreign material, to form a biofilm, and to display resistance to multiple antibiotics [<a href="#rid3">3</a>].</p><p>The following discussion will emphasize the issues specific to both native valve endocarditis and prosthetic valve endocarditis caused by CoNS. Discussion of CoNS infections at other sites is also included. General discussions related to the diagnosis and treatment of infective endocarditis and to the epidemiology, microbiology, pathogenesis, and antibiotic resistance patterns of CoNS are presented separately. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/3158.html" rel="external">"Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis"</a> and  <a class="medical medical_review" href="/z/d/html/3154.html" rel="external">"Infection due to coagulase-negative staphylococci: Treatment"</a>.)</p><p class="headingAnchor" id="H2927882"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H2928014"><span class="h2">Intravascular catheter infection</span><span class="headingEndMark"> — </span>CoNS remains the most common cause of catheter-related infections; in addition, most episodes of CoNS bacteremia are catheter related [<a href="#rid4">4</a>]. For short-term catheters, infection most commonly results from CoNS originating on the patient's skin, migrating via the cutaneous surface of the catheter to gain access to the bloodstream. For longer-term catheters, hub colonization and migration of organisms via the luminal surface is also important.</p><p>Clinical manifestations may be absent or include local findings (catheter site erythema and/or drainage) and/or systemic findings (fever, hypotension). Diagnosis and management of intravascular catheter infection are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a>.)</p><p>Distinguishing true infection from skin contamination is important; this is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3158.html" rel="external">"Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis", section on 'Distinguishing infection from contamination'</a>.)</p><p class="headingAnchor" id="H2"><span class="h2">Endocarditis</span><span class="headingEndMark"> — </span>CoNS are emerging as an important cause of native valve endocarditis (NVE) in both community and healthcare settings [<a href="#rid5">5,6</a>]. In addition, CoNS are among the most frequent causes of prosthetic valve endocarditis (PVE) within the first year after surgery [<a href="#rid7">7-11</a>].</p><p class="headingAnchor" id="H3"><span class="h3">Native valve</span><span class="headingEndMark"> — </span>The clinical presentation of NVE due to CoNS is similar to endocarditis due to viridans streptococci in that a prolonged duration of symptoms is common, although vascular and immunologic manifestations including Osler nodes, Janeway lesions, and Roth spots are somewhat less common with CoNS [<a href="#rid6">6</a>].</p><p>In the past, NVE due to CoNS was primarily a community-acquired infection [<a href="#rid12">12</a>]; more recent studies identify a high frequency of healthcare-associated infections [<a href="#rid6">6</a>]. This includes infections acquired in the hospital as well as infections in patients with extensive recent healthcare contact.</p><p>Data from one large study including more than 1500 cases of NVE noted that approximately 6 percent were caused by CoNS [<a href="#rid5">5</a>]. Compared with NVE due to <em>Staphylococcus aureus</em>, patients with NVE due to CoNS had lower rates of brain embolization (5 versus 24 percent) but higher rates of intracardiac abscess formation (15 versus 8 percent) and surgical intervention (54 versus 35 percent).</p><p>Compared with NVE due to viridans group streptococci, patients with NVE due to CoNS had higher rates of [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nosocomial endocarditis (40 versus 1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>A long-term intravascular catheter (20 versus 1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Heart failure (49 versus 31 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary embolus (5 versus 0.5 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Surgical intervention (54 versus 35 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>In-hospital mortality (19 versus 6.6 percent)</p><p></p><p>Another study noted that, among NVE cases not associated with injection drug use, CoNS were responsible for nearly 8 percent of cases, and nearly half were acquired in a healthcare setting [<a href="#rid6">6</a>]. Patients with NVE due to CoNS had a longer duration of symptoms prior to diagnosis as compared with patients with NVE due to <em>S. aureus</em>; despite this apparent delay in diagnosis, embolic events were less frequent among patients with NVE caused by CoNS. When compared with patients with NVE due to <em>S. aureus</em>, a larger proportion of patients with NVE due to CoNS had a pacemaker or implantable defibrillator [<a href="#rid6">6</a>].</p><p>Laboratory abnormalities including leukocytosis, anemia, and elevated inflammatory markers (erythrocyte sedimentation rate, C-reactive protein) are common. In one study, vegetations were demonstrated by echocardiogram in 89 percent of patients [<a href="#rid6">6</a>]. In another review of 21 patients, 14 developed complications including systemic embolization, heart failure, or new conduction system abnormalities, and 9 required surgical intervention [<a href="#rid12">12</a>].</p><p>The majority of isolates are <em>S. epidermidis</em>, although a variety of other species can be causative agents, including <em>S. lugdunensis</em>, <em>S. schleiferi,</em> <em>S. hominis</em>, <em>S. capitis</em>, and others [<a href="#rid5">5,6,13</a>]. Although most patients respond to antibiotic therapy, mortality rates of 13 to 25 percent have been reported [<a href="#rid5">5,6,12,14-16</a>].</p><p><em>S. lugdunensis</em> is an aggressive pathogen in the setting of NVE [<a href="#rid17">17</a>]. Its virulence is similar in many ways to that of <em>S. aureus</em>. In one series of 11 cases of S<em>. lugdunensis</em> IE, native valves were involved in 8 cases; valve destruction with abscess formation was observed in half of cases, with a mortality rate of 70 percent [<a href="#rid18">18</a>]. In another report, four patients presented with rapidly progressive valve destruction requiring prompt valve replacement [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/z/d/html/3155.html" rel="external">"Staphylococcus lugdunensis"</a>.)</p><p>The approach to treatment for NVE due to CoNS is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Prosthetic valve</span><span class="headingEndMark"> — </span>CoNS are the second most common cause of prosthetic valve endocarditis, after <em>S. aureus</em> [<a href="#rid20">20,21</a>]. In a series of 69 cases of PVE due to CoNS, 33 occurred between 60 and 365 days, and 82 percent of strains were <em>S. epidermidis</em>; 57 percent underwent surgery [<a href="#rid21">21</a>]. Early cases occurring within the first year are thought to result from introduction of bacteria at the time of surgery. Coagulase-negative staphylococci were also the most frequent isolates in cases of transcatheter implanted aortic valve endocarditis [<a href="#rid22">22</a>].</p><p>The infecting isolates in early PVE usually have a phenotype characteristic of nosocomial acquisition; they tend to form biofilm and to be resistant to multiple antibiotic families. CoNS have been isolated from numerous sources in the operating room, including bypass equipment, bone saws, and the prosthesis itself, and surgeons have been implicated as the source of contamination in point-source outbreaks for both wound infections and PVE [<a href="#rid23">23,24</a>].</p><p>Early PVE due to CoNS is often locally destructive. In one series of 55 patients, prosthetic valve dysfunction due to annular infection was found in 38 patients and perivalvular extension resulting in abscess formation in 17 patients [<a href="#rid25">25</a>].</p><p>The main challenge in interpreting blood cultures positive for CoNS in patients with PVE is distinguishing infection from contamination. Obtaining multiple blood cultures, separated over time, with assiduous attention to sterile technique to minimize culture contamination, is crucial in making this distinction. If a patient with a prosthetic valve has sporadically positive cultures, evaluation of antimicrobial susceptibility and techniques for determining the clonal origin of CoNS isolates should be applied. (See  <a class="medical medical_review" href="/z/d/html/3158.html" rel="external">"Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis", section on 'Identification'</a>.)</p><p>The mortality associated with PVE remains high despite earlier diagnosis of infection and the use of a combined surgical and medical approach for early infections. Treatment choices for staphylococcal PVE are the same regardless of whether the pathogen is coagulase negative or <em>S. aureus</em>. (See  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a>.)</p><p class="headingAnchor" id="H2928225"><span class="h2">Cardiac devices</span><span class="headingEndMark"> — </span>CoNS (predominantly <em>S. epidermidis</em>) account for at least 25 percent of cardiac device infections and may occur via inoculation at the time of device placement or by hematogenous seeding from another site. The microbiology, clinical presentation, diagnosis, and treatment of these infections are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2146.html" rel="external">"Infections involving cardiac implantable electronic devices: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H13084010"><span class="h2">Vascular graft infection</span><span class="headingEndMark"> — </span>Prosthetic vascular graft infection rates range from 1 to 6 percent, depending on the graft location; infrainguinal grafts deriving from the groin have the highest rates of infection [<a href="#rid26">26</a>]. CoNS are common causes of these infections. In early-onset infections (≤4 months), fever and local signs of infection are often present. Late-onset infections are frequently more difficult to diagnose. Symptoms may be clinically occult with patients having fever and fatigue but with few localizing findings [<a href="#rid27">27</a>]. Diagnosis is generally made by physical examination and radiographic imaging with demonstration of a sinus tract or pseudoaneurysm at the vascular anastomosis site. Positron emission tomography (PET) scans may be useful in establishing the diagnosis, but more study is needed [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H2928232"><span class="h2">Orthopedic infection</span><span class="headingEndMark"> — </span>CoNS are a common cause of infection of prosthetic orthopedic devices. The organisms are frequently inoculated at the time of the arthroplasty, and infection may present indolently. The clinical manifestations, diagnosis, and treatment of prosthetic joint infections are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/7664.html" rel="external">"Prosthetic joint infection: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7665.html" rel="external">"Prosthetic joint infection: Treatment"</a>.)</p><p class="headingAnchor" id="H2928239"><span class="h2">Central nervous system shunt infection</span><span class="headingEndMark"> — </span>About half of shunt infections are due to CoNS. These infections are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/1286.html" rel="external">"Infections of cerebrospinal fluid shunts"</a>.)</p><p class="headingAnchor" id="H117067013"><span class="h2">Breast implant infections</span><span class="headingEndMark"> — </span>Coagulase-negative staphylococci are also among the most common causes of infection following breast implant and reconstructive surgery. Early infections may present with localized signs of erythema, drainage, and pain as well as fever, while the more indolent late infections may present with drainage, chronic pain, and, infrequently, capsular contracture [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/5536.html" rel="external">"Breast implant infections"</a>.)</p><p class="headingAnchor" id="H2928246"><span class="h2">Surgical site infection</span><span class="headingEndMark"> — </span>CoNS are an important cause of surgical site infection (SSI). In some surgical procedures (such as coronary artery bypass surgery and some orthopedic procedures), CoNS are the second most common cause of SSI after <em>S. aureus </em>[<a href="#rid29">29</a>].</p><p>CoNS are more often cultured from superficial incisional wounds than deeper wounds and are more likely to cause infections in "clean" procedures. Diagnosis is made by culture of CoNS as the predominant isolate or repeated isolation of the same organism in serial cultures [<a href="#rid30">30</a>].</p><p>CoNS are among the most common causes of the endophthalmitis that can complicate approximately 0.1 percent of cataract surgeries. It is also a cause of postinjection endophthalmitis following the intravitreal injection of antivascular endothelial growth factor to treat macular degeneration [<a href="#rid31">31-33</a>].</p><p class="headingAnchor" id="H477978838"><span class="h2">Animal bite wound</span><span class="headingEndMark"> — </span><em>Staphylococcus intermedius</em> is a common part of animal oral flora and is an important pathogen in bite wounds [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H3557408753"><span class="h2">Urinary tract infection</span><span class="headingEndMark"> — </span><em>Staphylococcus saprophyticus</em> is a common cause of urinary tract infection; it is almost always methicillin-susceptible [<a href="#rid35">35</a>]. </p><p class="headingAnchor" id="H2929015"><span class="h1">INFECTION IN NEONATES</span><span class="headingEndMark"> — </span>Neonates are at particularly high-risk for infection due to CoNS [<a href="#rid36">36-38</a>]. CoNS are the most frequently isolated organisms associated with late-onset neonatal sepsis. Risk factors include prematurity, very low birth weight, central line placement, receipt of total <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a>, and prolonged hospitalization [<a href="#rid39">39,40</a>]. Clinical features are often nonspecific and may include temperature instability, hypoxemia, apnea, bradycardia, gastrointestinal disturbances, and lethargy or irritability [<a href="#rid39">39-41</a>]. </p><p>The extent to which neonatal CoNS infections are associated with increased morbidity, including sequelae such as neurodevelopmental impairments, remains unclear [<a href="#rid37">37,40,42</a>]. Our understanding of the outcomes of CoNS sepsis has been hampered by the lack of a uniform approach to diagnosis, particularly in terms of distinguishing clinically relevant isolates from contaminants [<a href="#rid39">39,40</a>].</p><p class="headingAnchor" id="H85356585"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Coagulase-negative staphylococci (CoNS) are a major constituent of human skin flora. These organisms have become increasingly recognized as agents of nosocomial bloodstream infections. Patients at risk include those with prosthetic devices and immunocompromised hosts. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most CoNS bloodstream infections are related to intravascular catheters. Clinical manifestations may include fever, hypotension, and leukocytosis. (See <a class="local">'Intravascular catheter infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CoNS are emerging as an important cause of native valve endocarditis in both community and healthcare settings. In addition, CoNS are the most frequent cause of prosthetic valve endocarditis within the first year after surgery. (See <a class="local">'Endocarditis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CoNS (predominantly <em>Staphylococcus epidermidis</em>) account for at least 25 percent of cardiac device infections and may occur via inoculation at the time of device placement or by hematogenous seeding from another site. (See <a class="local">'Cardiac devices'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CoNS are a common cause of vascular graft infection. In early-onset infections, local signs of infection are often present, while late-onset infections may be clinically occult and difficult to diagnose. (See <a class="local">'Vascular graft infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CoNS are a common cause of infection of prosthetic orthopedic devices. The organisms are frequently inoculated at the time of the arthroplasty, and infection may present indolently. (See <a class="local">'Orthopedic infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Surgical site infections due to CoNS are second only to <em>S. aureus</em> as an etiologic agent. CoNS are more often cultured from superficial incisional wounds than deeper wounds and are more likely to cause infections in "clean" procedures. (See <a class="local">'Surgical site infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neonates are a particularly high-risk group for CoNS infection. Risk factors include prematurity, very low birth weight, central line placement, receipt of total <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a>, and prolonged hospitalization. Clinical manifestations may include temperature instability, hypoxemia, apnea, bradycardia, gastrointestinal disturbances, and lethargy or irritability. (See <a class="local">'Infection in neonates'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Roth RR, James WD. Microbial ecology of the skin. Annu Rev Microbiol 1988; 42:441.</a></li><li><a class="nounderline abstract_t">Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190.</a></li><li><a class="nounderline abstract_t">Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350:1422.</a></li><li><a class="nounderline abstract_t">Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23:73.</a></li><li><a class="nounderline abstract_t">Chu VH, Cabell CH, Abrutyn E, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004; 39:1527.</a></li><li><a class="nounderline abstract_t">Chu VH, Woods CW, Miro JM, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46:232.</a></li><li><a class="nounderline abstract_t">López J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007; 28:760.</a></li><li><a class="nounderline abstract_t">Gordon SM, Serkey JM, Longworth DL, et al. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg 2000; 69:1388.</a></li><li><a class="nounderline abstract_t">Castillo JC, Anguita MP, Torres F, et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol 2004; 93:1185.</a></li><li><a class="nounderline abstract_t">Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001; 85:590.</a></li><li><a class="nounderline abstract_t">Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg 2010; 139:887.</a></li><li><a class="nounderline abstract_t">Caputo GM, Archer GL, Calderwood SB, et al. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987; 83:619.</a></li><li><a class="nounderline abstract_t">Petti CA, Simmon KE, Miro JM, et al. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol 2008; 46:1780.</a></li><li><a class="nounderline abstract_t">Williams DN, Peterson PK, Verhoef J, et al. Endocarditis caused by coagulase-negative staphylococci. Infection 1979; 7:5.</a></li><li><a class="nounderline abstract_t">Geraci JE, Hanson KC, Giuliani ER. Endocarditis caused by coagulase-negative staphylococci. Mayo Clin Proc 1968; 43:420.</a></li><li><a class="nounderline abstract_t">Carugati M, Petti CA, Arnold C, et al. Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis. Antimicrob Agents Chemother 2016; 60:6341.</a></li><li><a class="nounderline abstract_t">Liu PY, Huang YF, Tang CW, et al. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J Microbiol Immunol Infect 2010; 43:478.</a></li><li><a class="nounderline abstract_t">Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993; 17:871.</a></li><li><a class="nounderline abstract_t">Lessing MP, Crook DW, Bowler IC, Gribbin B. Native-valve endocarditis caused by Staphylococcus lugdunensis. QJM 1996; 89:855.</a></li><li><a class="nounderline abstract_t">Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354.</a></li><li><a class="nounderline abstract_t">Chu VH, Miro JM, Hoen B, et al. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 2009; 95:570.</a></li><li><a class="nounderline abstract_t">Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 2015; 131:1566.</a></li><li><a class="nounderline abstract_t">van den Broek PJ, Lampe AS, Berbée GA, et al. Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis. Br Med J (Clin Res Ed) 1985; 291:949.</a></li><li><a class="nounderline abstract_t">Boyce JM, Potter-Bynoe G, Opal SM, et al. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 1990; 161:493.</a></li><li><a class="nounderline abstract_t">Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983; 98:447.</a></li><li><a class="nounderline abstract_t">O'Brien T, Collin J. Prosthetic vascular graft infection. Br J Surg 1992; 79:1262.</a></li><li><a class="nounderline abstract_t">Leroy O, Meybeck A, Sarraz-Bournet B, et al. Vascular graft infections. Curr Opin Infect Dis 2012; 25:154.</a></li><li><a class="nounderline abstract_t">Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5:94.</a></li><li><a class="nounderline abstract_t">Sharma M, Berriel-Cass D, Baran J Jr. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004; 25:468.</a></li><li><a class="nounderline abstract_t">Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20:271.</a></li><li><a class="nounderline abstract_t">Gentile RC, Shukla S, Shah M, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 2014; 121:1634.</a></li><li><a class="nounderline abstract_t">Durand ML. Endophthalmitis. Clin Microbiol Infect 2013; 19:227.</a></li><li><a class="nounderline abstract_t">Ormerod LD, Ho DD, Becker LE, et al. Endophthalmitis caused by the coagulase-negative staphylococci. 1. Disease spectrum and outcome. Ophthalmology 1993; 100:715.</a></li><li><a class="nounderline abstract_t">Goldstein EJ. Bite wounds and infection. Clin Infect Dis 1992; 14:633.</a></li><li><a class="nounderline abstract_t">Hovelius B, Mårdh PA. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984; 6:328.</a></li><li><a class="nounderline abstract_t">Isaacs D, Australasian Study Group For Neonatal Infections. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003; 88:F89.</a></li><li><a class="nounderline abstract_t">Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol 2013; 2013:586076.</a></li><li><a class="nounderline abstract_t">Heo JS, Shin SH, Jung YH, et al. Neonatal sepsis in a rapidly growing, tertiary neonatal intensive care unit: Trends over 18 years. Pediatr Int 2015; 57:909.</a></li><li><a class="nounderline abstract_t">Healy CM, Baker CJ, Palazzi DL, et al. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol 2013; 33:52.</a></li><li><a class="nounderline abstract_t">Nash C, Chu A, Bhatti M, et al. Coagulase Negative Staphylococci in the Neonatal Intensive Care Unit: Are We Any Smarter? Neoreviews 2013; 14:e284.</a></li><li><a class="nounderline abstract_t">Healy CM, Palazzi DL, Edwards MS, et al. Features of invasive staphylococcal disease in neonates. Pediatrics 2004; 114:953.</a></li><li><a class="nounderline abstract_t">Jean-Baptiste N, Benjamin DK Jr, Cohen-Wolkowiez M, et al. Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2011; 32:679.</a></li></ol></div><div id="topicVersionRevision">Topic 2137 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3144238" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Microbial ecology of the skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19478181" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Topographical and temporal diversity of the human skin microbiome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15070792" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Treatment of infections associated with surgical implants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19135917" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Coagulase-negative staphylococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15546091" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18171255" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17255216" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10881810" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15110221" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Long-term prognosis of early and late prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11303018" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19660339" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3674050" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18367572" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/253687" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Endocarditis caused by coagulase-negative staphylococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5190668" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Endocarditis caused by coagulase-negative staphylococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27527083" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Antistaphylococcalβ-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21195974" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8286628" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8977965" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Native-valve endocarditis caused by Staphylococcus lugdunensis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392239" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Contemporary clinical profile and outcome of prosthetic valve endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18952633" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25753535" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3929975" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2179423" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6838067" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1486415" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prosthetic vascular graft infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22248976" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Vascular graft infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15680779" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Infection in breast implants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15242193" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1332552" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24702755" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23438028" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Endophthalmitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8493015" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Endophthalmitis caused by the coagulase-negative staphylococci. 1. Disease spectrum and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1562653" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Bite wounds and infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377440" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Staphylococcus saprophyticus as a common cause of urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598493" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23762094" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Neonatal sepsis due to coagulase-negative staphylococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25819546" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Neonatal sepsis in a rapidly growing, tertiary neonatal intensive care unit: Trends over 18 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22499081" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Coagulase Negative Staphylococci in the Neonatal Intensive Care Unit: Are We Any Smarter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15466090" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Features of invasive staphylococcal disease in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21666399" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Coagulase-negative staphylococcal infections in the neonatal intensive care unit.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
